Class IITerminated in FDA datasetRecall initiated Nov 20, 2025

Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with…

Recalling firm: A New Life Herbs, LLC

Why it was recalled

Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Aug 28, 2026.

Check your package

Compare the exact product and package details with the label you have.

ProductBoswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420
Package size2 oz
UPC284260392420

FDA code information

T848B EXP 11/30 T836B EXP 10/30 T808B EXP 9/30 T771B EXP 7/30 T723B EXP 3/30 T696B EXP 1/29 T655B EXP 10/29 T594B EXP 4/29 T536B EXP 10/28

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420

Extracted codes and context

TypeCode / valueContext
UPC284260392420, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420

Original FDA recall reason

Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label

Recall details

Recall number
H-0343-2026
Event ID
98037
FDA status
Terminated
Initiated
Nov 20, 2025
Reported
Dec 31, 2025
Classified
Dec 23, 2025
Terminated
Aug 28, 2026
Quantity
278 bottles
Location
Somerville, TN, United States
Initiation type
Voluntary: Firm initiated
Notification
E-Mail

Where it was distributed

AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN

FDA source record · H-0343-2026

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.